Images of the Future
More than any other branch of medicine, nuclear medicine teaches us that structure and function are but two aspects of the same thing. In biological systems what we call structures are slow processes of long duration. What we call functions are fast processes of short duration. Nuclear images are symbolic representations of the patterns and changes in the spatial and temporal distribution of the chemical substances that make up our bodies. Until now, our major concepts of disease have been based on the discipline of gross pathology, which provides a limited sort of information analogous to that obtained from an archeological excavation.
KeywordsDopamine Receptor Radioactive Tracer Opiate Receptor Nuclear Magnetic Resonance Imaging Cerebral Glucose Metabolism
Unable to display preview. Download preview PDF.
- 2.Ter-Pogossian, M.M. and H.N. Wagner, Jr. “A new look at the cyclotron for making short-lived isotopes.” Nucleonics 24 (1966) 50-56.Google Scholar
- 4.Ido, T., C.N. Wan, V. Casella, et al. “Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-12-fluoro-D-glucose.” Journal of Labelled Compounds and Radiopharmaceuticals 24 (1978) 174-183.Google Scholar
- 6.Sokoloff, L., M. Reivich, C. Kennedy, et al. “The (14C) deoxyglucose method for the measurement of local cerebral glucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat.” Journal of Neurochemistry 28 (1977) 897-916.PubMedCrossRefGoogle Scholar
- 10.Kuhar, M.J. “Histochemical localization of neurotransmitter receptors,” in H.I. Yamamura, S.J. Enna and M.J. Kuhar, eds., Neurotransmitter Receptor Binding 1978 (Raven Press, New York).Google Scholar
- 11.Creese, I. “Receptor binding as a primary drug screening device,” in H.I. Yamamura, S.J. Enna and M.J. Kuhar, eds., Neurotransmitter Receptor Binding 1978 (Raven Press, New York).Google Scholar